You are here

  • Home
  • Archive
  • Volume 12, Issue 3
  • Nivolumab-induced hypophysitis leading to hypopituitarism and secondary empty sella syndrome in a patient with non-small cell lung cancer

Article info

Article menu
Download PDFPDF
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
Nivolumab-induced hypophysitis leading to hypopituitarism and secondary empty sella syndrome in a patient with non-small cell lung cancer

Authors

  1. Correspondence to Dr Jeremy Chang, jeremy.chang{at}med.usc.edu
View Full Text

Citation

Chang J, Tran J, Kamel D, et al
Nivolumab-induced hypophysitis leading to hypopituitarism and secondary empty sella syndrome in a patient with non-small cell lung cancer
BMJ Case Reports CP 2019;12:e228135.

Publication history

  • Accepted February 6, 2019
  • First published March 7, 2019.
Online issue publication 
March 07, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.